The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Director/PDMR Shareholding

17 Sep 2019 08:24

RNS Number : 5088M
Medica Group PLC
17 September 2019
 

Medica Group PLC

 

Director / PDMR Shareholding

 

Medica Group PLC (the "Company") announces that on 16 September 2019, the PDMR listed below was granted options over ordinary shares of 0.2p each in the Company under the Company's Performance Share Plan 2017 at a nil exercise price:

 

Name of PDMR

Number of shares subject to option

Dr Stuart Quin

533,682

 

The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation and set out more details of the transactions.

 

1.

Details of PDMR

(a)

Name

1. Dr Stuart Quin

 

2.

Reason for notification

(b)

Position / status

1. Chief Executive Officer

 

(c)

Initial notification / amendment

Initial notification in each case

3.

Details of the Issuer

(a)

Name

Medica Group PLC

(b)

LEI

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted

(a)

Description of the financial instrument

Ordinary shares of 0.2p each in the capital of the Company ("Shares")

(b)

Nature of the transaction

Grant of options to acquire Shares pursuant to the Company's Performance Share Plan 2017

(c)

Price(s) and volume

Exercise Price nil

 

(d)

Aggregated information

N/A

(e)

Date of the transaction

16 September 2019

(f)

Place of the transaction

Outside a trading venue

 

 

 

-ENDS-

 

For further details contact:

 

Medica Group:

+44 (0)33 33 111 222

Stuart Quin, Chief Executive Officer

Tony Lee, Chief Financial Officer

FTI Consulting

+44 (0)20 3727 1000

Brett Pollard

Victoria Foster Mitchell

Robert Winder

 

 

About Medica

Medica is the UK market leader by revenue in the provision of teleradiology services, providing outsourced interpretation and reporting on MRI (magnetic resonance imaging), CT (computerised tomography) and plain film (x-ray) images. The Company currently offers three primary services to hospital radiology departments: NightHawk, an out-of-hours service, routine cross-sectional (Routine CS) reporting on MRI and CT scans, and routine plain film (Routine PF) reporting on x-ray images.

 

Medica has developed a bespoke secure IT platform that provides market-leading linkage between a hospital's Radiology Information System (RIS) and Consultant Radiologists who contract with Medica. Direct RIS access ensures that the full wider patient information is available and reviewed with every report.

 

The Company contracts with the largest pool of consultant radiologists outside of the NHS and has been trusted to provide more than 1.5 million examinations annually across its customer base of more than 100 NHS hospitals and various private hospital groups and diagnostic imaging companies. For more information please visit www.medicagroup.co.uk 

 

About teleradiology

Teleradiology is the electronic transmission of radiological patient images, including plain film (x-rays), CT scans and MRI scans, from one location to another for the purposes of diagnostic interpretation and reporting.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHCKADPPBKDDCD

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.